BFG
TNGX icon

Bleakley Financial Group’s Tango Therapeutics TNGX Stock Holding History

Bleakley Financial Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Sell
12,302
-79
-0.6% -$1.95K ﹤0.01% 841
2026
Q1 		$259K Buy
+12,381
New +$172K ﹤0.01% 728
2025
Q1 		– Sell
-12,849
Closed -$39.7K – 955
2024
Q4 		$39.7K Sell
12,849
-1,578
-11% -$7.33K ﹤0.01% 1026
2024
Q3 		$111K Sell
14,427
-1,653
-10% -$15.8K ﹤0.01% 963
2024
Q2 		$138K Buy
+16,080
New +$124K ﹤0.01% 931

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Bleakley Financial Group's TNGX Position: Q2 2026 in Review

Bleakley Financial Group reduced its Tango Therapeutics (TNGX) stake by 0.64% in Q2 2026, selling an estimated $1.95K and leaving 12,302 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Bleakley Financial Group first reported a position in TNGX in Q2 2024 and has held it in 5 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Bleakley Financial Group held 12,302 shares of Tango Therapeutics worth $385K as of Q2 2026.
  • Bleakley Financial Group sold 79 Tango Therapeutics shares in Q2 2026, an estimated $1.95K.
  • Tango Therapeutics made up ﹤0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #841 holding.
  • Bleakley Financial Group first reported a position in Tango Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.